Nonetheless, data from most studies are in favor of an indispensable role of IL-17/Th17 cells in the development of T1D which is supported by the therapeutic effect of IL-17 blockade by anti-IL-17 antibody or IL-25 [16]. The gene discussed is IL17A; the disease is type 1 diabetes mellitus.